Drawing for BUOY

USPTO serial 99469211

BUOY

Reviewed by CopyMark Law Group

Status 653
Filing date
Status date
Registration date
—
Examiner
SANCHEZ RIVERA, MARIA C.
Law office
TMO LAW OFFICE 112

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BUOY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nicholas B. Hawkins

Nicholas B. Hawkins Womble Bond Dickinson (US) LLP888 Seventh Avenue38th FloorNew York, NY 10106

Goods and services

ClassDescriptionStatusFirst use
005Technologies in the nature of pharmaceutical preparations of drugs that facilitate the delivery of pharmaceutical compounds for oral administration of therapeutics utilizing the lymphatic system to treat human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, neuropsychiatric disorders, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseasesACTIVE—
009Downloadable application software for accessing and managing clinical trial dataACTIVE—
042Providing access to non-downloadable software for accessing clinical trials and managing clinical trial dataACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 12, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 12, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 12, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Jan 12, 2026CNSLSUSPENSION LETTER WRITTEN—
Dec 30, 2025DOCKASSIGNED TO EXAMINER—
Oct 29, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 29, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 29, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance